Login / Signup

Editorial Comment on "Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin".

Koji Hatano
Published in: IJU case reports (2022)
Keyphrases
  • editorial comment
  • breast cancer risk
  • newly diagnosed